These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 29045907)

  • 1. Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy.
    Glodde N; Bald T; van den Boorn-Konijnenberg D; Nakamura K; O'Donnell JS; Szczepanski S; Brandes M; Eickhoff S; Das I; Shridhar N; Hinze D; Rogava M; van der Sluis TC; Ruotsalainen JJ; Gaffal E; Landsberg J; Ludwig KU; Wilhelm C; Riek-Burchardt M; Müller AJ; Gebhardt C; Scolyer RA; Long GV; Janzen V; Teng MWL; Kastenmüller W; Mazzone M; Smyth MJ; Tüting T; Hölzel M
    Immunity; 2017 Oct; 47(4):789-802.e9. PubMed ID: 29045907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.
    Marshall NA; Galvin KC; Corcoran AM; Boon L; Higgs R; Mills KH
    Cancer Res; 2012 Feb; 72(3):581-91. PubMed ID: 22158905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
    Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
    Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions.
    Ilangumaran S; Villalobos-Hernandez A; Bobbala D; Ramanathan S
    Cytokine; 2016 Jun; 82():125-39. PubMed ID: 26822708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells.
    Jiang L; Fang X; Wang H; Li D; Wang X
    Front Immunol; 2018; 9():2927. PubMed ID: 30619288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
    Li J; Hu P; Khawli LA; Epstein AL
    Cancer Res; 2003 Dec; 63(23):8384-92. PubMed ID: 14679000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy.
    Lechner MG; Karimi SS; Barry-Holson K; Angell TE; Murphy KA; Church CH; Ohlfest JR; Hu P; Epstein AL
    J Immunother; 2013; 36(9):477-89. PubMed ID: 24145359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The c-MET receptor tyrosine kinase contributes to neutrophil-driven pathology in cutaneous leishmaniasis.
    Passelli K; Prat-Luri B; Merlot M; Goris M; Mazzone M; Tacchini-Cottier F
    PLoS Pathog; 2022 Jan; 18(1):e1010247. PubMed ID: 35041723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
    Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
    Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transfer.
    Kobold S; Steffen J; Chaloupka M; Grassmann S; Henkel J; Castoldi R; Zeng Y; Chmielewski M; Schmollinger JC; Schnurr M; Rothenfußer S; Schendel DJ; Abken H; Sustmann C; Niederfellner G; Klein C; Bourquin C; Endres S
    J Natl Cancer Inst; 2015 Jan; 107(1):364. PubMed ID: 25424197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment.
    Kim KD; Bae S; Capece T; Nedelkovska H; de Rubio RG; Smrcka AV; Jun CD; Jung W; Park B; Kim TI; Kim M
    Nat Commun; 2017 May; 8():15365. PubMed ID: 28504276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
    Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
    Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance.
    Zheng W; Skowron KB; Namm JP; Burnette B; Fernandez C; Arina A; Liang H; Spiotto MT; Posner MC; Fu YX; Weichselbaum RR
    Oncotarget; 2016 Jul; 7(28):43039-43051. PubMed ID: 27343548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers.
    Ekiz HA; Huffaker TB; Grossmann AH; Stephens WZ; Williams MA; Round JL; O'Connell RM
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30721153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HGF-independent regulation of MET and GAB1 by nonreceptor tyrosine kinase FER potentiates metastasis in ovarian cancer.
    Fan G; Zhang S; Gao Y; Greer PA; Tonks NK
    Genes Dev; 2016 Jul; 30(13):1542-57. PubMed ID: 27401557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.
    Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M
    Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MET is required for the recruitment of anti-tumoural neutrophils.
    Finisguerra V; Di Conza G; Di Matteo M; Serneels J; Costa S; Thompson AA; Wauters E; Walmsley S; Prenen H; Granot Z; Casazza A; Mazzone M
    Nature; 2015 Jun; 522(7556):349-53. PubMed ID: 25985180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment.
    Wallecha A; Singh R; Malinina I
    J Immunother; 2013; 36(9):468-76. PubMed ID: 24145358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.
    Gui Y; Yeganeh M; Donates YC; Tobelaim WS; Chababi W; Mayhue M; Yoshimura A; Ramanathan S; Saucier C; Ilangumaran S
    Oncogene; 2015 Nov; 34(46):5718-28. PubMed ID: 25728680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.